URNEVA- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, hyoscyamine sulfate capsule

Country: Amerika Syarikat

Bahasa: Inggeris

Sumber: NLM (National Library of Medicine)

Bahan aktif:

METHENAMINE (UNII: J50OIX95QV) (METHENAMINE - UNII:J50OIX95QV), SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN) (PHOSPHATE ION - UNII:NK08V8K8HR, SODIUM CATION - UNII:LYR4M0NH37), PHENYL SALICYLATE (UNII: 28A37T47QO) (PHENYL SALICYLATE - UNII:28A37T47QO), METHYLENE BLUE (UNII: T42P99266K) (METHYLENE BLUE CATION - UNII:ZMZ79891ZH), HYOSCYAMINE SULFATE (UNII: F2R8V82B84) (HYOSCYAMINE - UNII:PX44XO846X)

Boleh didapati daripada:

Scite Pharma, LLC

Laluan pentadbiran:

ORAL

Jenis preskripsi:

PRESCRIPTION DRUG

Tanda-tanda terapeutik:

UrNeva Capsules is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures. UrNeva Capsules is contraindicated in patients with a hypersensitivity to any of the ingredients. Risk-benefit should be considered when the following medical problems exist: Cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). A dependence on the use of UrNeva Capsules has not been reported and due to the nature of its ingredients, abuse of UrNeva Capsules is not expected.

Ringkasan produk:

UrNeva Capsules are light red capsules imprinted with 338, available in bottles of 60 capsules, (NDC: 79043-338-60), and sample tablets of 1, (NDC: 79043-338-99).

Status kebenaran:

unapproved drug other

Ciri produk

URNEVA- METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL
SALICYLATE, METHYLENE BLUE, HYOSCYAMINE SULFATE CAPSULE
SCITE PHARMA, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
URNEVA
RX ONLY
DESCRIPTION
UrNeva Capsules for oral administration.
EACH CAPSULE CONTAINS:
Methenamine 120
mg
Sodium Phosphate Monobasic 40.8
mg
Phenyl Salicylate 36.2
mg
Methylene Blue 10.8
mg
Hyoscyamine Sulfate 0.12
mg
INACTIVE INGREDIENTS:lactose monohydrate, polyethylene glycol,
crospovidone,
magnesium stearate, silicified microcrystalline cellulose, FD&C Blue
#1, FD&C Red #3,
titanium dioxide, gelatin.
METHENAMINE
[100-97-0] 1,3,5,7-Tetraazatricyclo [3.3.1.-1
] decane; hexamethylenetetramine; HMT;
HMTA; hexamine; 1,3,5,7-tetraazaadamantane
hexamethylenemine; Uritone; Urotropin. C
H
N
; mol wt 140.19; C 51.40%, H 8.63%,
N 39.96%. Methenamine (hexamethylenetetramine)
exists as colorless, lustrous crystals or white crystalline powder.
Its solutions are
alkaline to litmus. Freely soluble in water, soluble in alcohol
and in chloroform.
SODIUM PHOSPHATE MONOBASIC
3,7
6
12
4
[7558-80-7] Phosphoric acid sodium salt (1:1); Sodium biphosphate;
sodium dihydrogen
phosphate; acid sodium phosphate; monosodium orthophosphate; primary
sodium
phosphate; H
NaO
P; mol wt 119.98, H 1.68%, Na 19.16%, O 53.34%, P 25.82%.
Monohydrate, white, odorless slightly deliquesce crystals or granules.
At 100° C loses all
its water; when ignited it converts to metaphosphate. It is freely
soluble in water and
practically insoluble in alcohol. The aqueous solution is acid. pH of
0.1 molar aqueous
solution at 25° C: 4.5.
PHENYL SALICYLATE
[118-55-8] 2-Hydroxybenzoic acid phenyl ester; Salol. C
H
O
; mol wt 214.22, C
72.89%, H 4.71%, O 22.41%. Made by the action of phosphorus
oxy-chloride on a
mixture of phenol and salicylic acid. Phenyl Salicylate exists as
white crystals with a
melting point of 41°-43°